Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ping Hai Zhang"'
Autor:
Qing Zhou, Yong Song, Xin Zhang, Gong-Yan Chen, Dian-Sheng Zhong, Zhuang Yu, Ping Yu, Yi-Ping Zhang, Jian-Hua Chen, Yi Hu, Guo-Sheng Feng, Xia Song, Qiang Shi, Lu Lu Yang, Ping Hai Zhang, Yi-Long Wu
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-7 (2017)
Abstract Background In recent years, systemic chemotherapy and molecular targeted therapy have become standard first-line treatments for locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC). The objective of this survey was t
Externí odkaz:
https://doaj.org/article/d704809899a247469636f1cc7c6b21f6
Autor:
Xia Song, Xin Zhang, Zhuang Yu, Lu Lu Yang, Dian-Sheng Zhong, Ping Yu, Ping hai Zhang, Qing Zhou, Qiang Shi, Yong Song, Yi-Long Wu, Guosheng Feng, Yi Hu, Jianhua Chen, Gongyan Chen, Yiping Zhang
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-7 (2017)
BMC Cancer
BMC Cancer
Background In recent years, systemic chemotherapy and molecular targeted therapy have become standard first-line treatments for locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC). The objective of this survey was to investi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fc07a6a2f1a8eb77c4f5712096eb744
http://link.springer.com/article/10.1186/s12885-017-3451-x
http://link.springer.com/article/10.1186/s12885-017-3451-x
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 115
Objectives In the JMEN trial, patients with advanced non-squamous non-small cell lung cancer (NSCLC) without progression after platinum-based first-line therapy derived extended survival, delayed disease progression, and maintained overall quality of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d958ac9b6867a0b132a0751d5e52803
https://pubmed.ncbi.nlm.nih.gov/29290253
https://pubmed.ncbi.nlm.nih.gov/29290253
Autor:
Ping-hai Zhang, Tarun Puri, Feng-Ming Hsu, Mauro Orlando, Yi-Long Wu, Lei Deng, Shun Lu, Neill Iscoe, Anwar Hossain, Myung-Ju Ahn, Luhua Wang
Publikováno v:
Asia-Pacific journal of clinical oncology. 12(4)
Aim PROCLAIM, a phase III trial of patients with nonsquamous non–small cell lung cancer comparing concurrent pemetrexed-cisplatin and thoracic radiation therapy followed by consolidation pemetrexed, did not meet its primary endpoint of superior ove
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::863ba8f0fb0255e78e0e444f0919569d
https://pubmed.ncbi.nlm.nih.gov/27312514
https://pubmed.ncbi.nlm.nih.gov/27312514
Publikováno v:
Zhonghua yi xue za zhi. 89(34)
To investigate the change of proliferation and invasiveness of non-small cell lung cancer (NSCLC) cell lines SPC-A-1, A549 and LTEP-a-2 with forkhead box M1 (FoxM1) expression deficiency.A siRNA targeting FoxM1 was designed to deplete the FoxM1 expre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::01d4b19a5389aecfd61f3f865beb55e5
https://pubmed.ncbi.nlm.nih.gov/20137699
https://pubmed.ncbi.nlm.nih.gov/20137699
Autor:
Ping-hai, Zhang, Bi-jie, Hu, Li-xian, He, Hua-yin, Li, Bao-qing, Wang, Xue-hua, Chen, Jue, Pan, Hong-ni, Jiang, Chun-mei, Zhou, Xiao-dong, Gao, Hong-mei, Xie, Sheng-lei, Huang, Wen-song, Xia, Li-li, Tao, Chun-xue, Bai
Publikováno v:
Zhonghua nei ke za zhi. 48(5)
To further elucidate the CT characteristics and diagnostic approaches to non-acquired immune deficiency syndrome patients with pulmonary cryptococcosis.The histories of forty-two pulmonary cryptococcosis (PC) patients diagnosed in Zhongshan Hospital
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::95bdbc4141c90d3444deb64d35834445
https://pubmed.ncbi.nlm.nih.gov/19615150
https://pubmed.ncbi.nlm.nih.gov/19615150
Autor:
James Chih-Hsin Yang, Xin Wang, Mauro Orlando, Ying Cheng, Shun Lu, Xiaoqing Zhang, Yi-Long Wu, Ping-hai Zhang, Caicun Zhou, Jie Wang
Publikováno v:
Clinical Lung Cancer. (5):e103-e112
Background Pemetrexed plus platinum has become a standard of care in first-line treatment for patients with advanced nonsquamous non–small-cell lung cancer. However, elderly lung cancer patients are generally understudied and undertreated in clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1698d9bcf5039a4418a6a826a6b90c24